MYDNA stands as a worldwide leader in Central Clinical Laboratory services, focusing on Oncology/Cancer Studies. Endorsed by the Institute of American Medics (IAM) and the Clinical Laboratory Improvement Amendments (CLIA), it has been serving the global community since 2009 and expanded its expertise to Europe as of June 2021.
MYDNA stands as a worldwide leader in Central Clinical Laboratory services, focusing on Oncology/Cancer Studies. Endorsed by the Institute of American Medics (IAM) and the Clinical Laboratory Improvement Amendments (CLIA), it has been serving the global community since 2009 and expanded its expertise to Europe as of June 2021.
100+
14 Y
50+
200K+
Dive into the world of clinical trials where safety meets innovation. Our trials are meticulously designed to test new treatments and drugs, ensuring they meet rigorous safety standards before they reach patients.
Stay abreast of breakthroughs that are changing the landscape of cancer treatment. Our cutting-edge research is dedicated to finding more effective strategies for diagnosis, treatment, and prevention.
Learn what it means to be part of a clinical study and how your participation can contribute to major medical advancements, offering hope to countless individuals facing cancer.
Delve into the latest advancements that tailor cancer treatment to the individual's genetic makeup, offering hope for more effective and targeted therapies.
Discover the cutting-edge tools and techniques we employ to detect and understand cancer at the molecular level, revolutionizing early diagnosis.
Learn about our global partnerships that foster innovation, driving forward the collective quest to conquer cancer.
Our commitment to ethical research upholds the dignity of all participants, ensuring that every discovery is made with the utmost respect for genetic privacy.
Your heart beats per minute.
Grasping the essentials of genetics and the influence of genes on health.
Delving into the genetic elements that contribute to cancer susceptibility.
Discussing the importance of genetic screening in familial health planning.
Dr. Wallace, our Chief Genomic Strategist, orchestrates advanced genetic research initiatives and clinical application.
Heading Medivance scientific investigations, Elena directs pivotal research programs as the Chief Genetics Investigator.
As the Lead Genetic Health Liaison, Dr. Yi ensures clients receive tailored guidance and support throughout their genomic exploration.
Mick, a seasoned Genomic Data Analyst, specializes in translating intricate genetic information into actionable insights for patients.
Medivance launched with a commitment to revolutionize genetic health research.
Achieved a major scientific breakthrough in genetic marker identification.
Expanded our testing services to include comprehensive genomic profiling.
Earned prestigious IAM and CLIA certifications for laboratory excellence.
Initiated international research partnerships, extending our impact worldwide.
Introduced state-of-the-art sequencing technology, enhancing diagnostic precision.
Adapted our research platforms to contribute to global COVID-19 genomic studies.
Expanded operations into Europe, establishing a new hub for research and development.
Surpassed 150,000 patients served with personalized genetic insights.
Currently pioneering next-generation gene therapies, setting new industry standards.